Interleukin-24 as a Pulmonary Target Cytokine in Bronchopulmonary Dysplasia
- PMID: 33683657
- DOI: 10.1007/s12013-021-00968-z
Interleukin-24 as a Pulmonary Target Cytokine in Bronchopulmonary Dysplasia
Abstract
The proliferation of fetal alveolar type II cells (FATIICs) was impaired in bronchopulmonary dysplasia (BPD), which is modulated by hyperoxia and inflammatory response. Interleukin 24 (IL-24), a cytokine produced by certain cell types, plays an essential role in inflammation and host protection against infection. However, the ability of FATIICs to produce IL-24 remains unclear, and the role of IL-24 in BPD progression is yet to be determined. With reverse transcription quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay, the authors evaluated whether FATIICs produce IL-24 in physiological conditions. The authors quantified IL-24 expression in the lungs of newborn rat pups exposed to hyperoxia (70% oxygen) and in FATIICs isolated on embryonic day 19 that were exposed to 95% oxygen or lipopolysaccharide (LPS). The role of IL-24 in FATIICs, cell proliferation, cell apoptosis, and cell cycle were further evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and flow cytometric analysis. Also, they assessed caspase-3 and SOCS3 mRNA in IL-24 siRNA-treated cells by using RT-qPCR. During culture, IL-24 mRNA and protein levels in FATIICs gradually decreased with FATIIC differentiation. IL-24 expression increased significantly in rat lungs exposed to hyperoxia and FATIICs exposed to oxygen or LPS. Recombinant IL-24 enhanced cell proliferation by decreasing the proportion of apoptotic cells and increasing the proportion of cells in the S phase. The IL-24 siRNA-treated cells expressed more caspase-3 mRNA. Furthermore, suppressor of cytokine signaling 3 (SOCS3) mRNA was significantly decreased in rats and FATIICs exposed to oxygen, whereas it dramatically increased in FATIICs exposed to LPS. The IL-24 siRNA-treated cells expressed more SOCS3 mRNA. These studies suggest IL-24 is a pulmonary target cytokine in BPD, and may possibly regulate SOCS3 in oxidative stress and inflammation of the lung.
Keywords: Bronchopulmonary dysplasia; Fetal alveolar type II cells; Hyperoxia; Interleukin-24; Proliferation.
References
-
- Morty, R. E. (2018). Recent advances in the pathogenesis of BPD. Seminars in Perinatology, 42(7), 404–412. https://doi.org/10.1053/j.semperi.2018.09.001 . - DOI - PubMed
-
- Reiterer, F., Scheuchenegger, A., Resch, B., Maurer-Fellbaum, U., Avian, A., & Urlesberger, B. (2019). Bronchopulmonary dysplasia in very preterm infants: outcome up to preschool age, in a single center of Austria. Pediatrics International, 61(4), 381–387. https://doi.org/10.1111/ped.13815 . - DOI - PubMed - PMC
-
- Cheong, J., & Doyle, L. W. (2018). An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Seminars in Perinatology, 42(7), 478–484. https://doi.org/10.1053/j.semperi.2018.09.013 . - DOI - PubMed
-
- Endesfelder, S., Strauss, E., Scheuer, T., Schmitz, T., & Buhrer, C. (2019). Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia. Respiratory Research, 20(1), 88 https://doi.org/10.1186/s12931-019-1063-5 . - DOI - PubMed - PMC
-
- Velten, M., Heyob, K. M., Rogers, L. K., & Welty, S. E. (2010). Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. Journal of Applied Physiology (1985), 108(5), 1347–1356. https://doi.org/10.1152/japplphysiol.01392.2009 . - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
